Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bradwejn

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Clinical Neuropharmacology|January 1, 1992
CCK agonists and antagonists in clinical studies of panic and anxietyJ Bradwejn
Psychiatric Journal of the University of Ottawa : Revue De Psychiatrie De L'Universite D'Ottawa|June 1, 1989
Depression: a review of acute pharmacological treatmentJ Bradwejn
Journal of Psychiatry & Neuroscience : JPN|July 1, 1993
Neurobiological investigations into the role of cholecystokinin in panic disorderJ Bradwejn
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 1, 1993
Benzodiazepines for the treatment of panic disorder and generalized anxiety disorder: clinical issues and future directionsJ Bradwejn
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1991
Comparison of the panicogenic effect of cholecystokinin 30-33 and carbon dioxide in panic disorderJ Bradwejn, D Koszycki
Archives of General Psychiatry|January 1, 1995
Relationship of panic disorder to posttraumatic stress disorderG Safadi, J Bradwejn
Annals of the New York Academy of Sciences|March 23, 1994
The cholecystokinin hypothesis of anxiety and panic disorderJ Bradwejn, D Koszycki
The American Journal of Psychiatry|March 1, 1982
Reversible and irreversible tardive dyskinesia: a case reportG Chouinard, J Bradwejn
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|May 1, 1991
[Clinical and neurobiological aspects of long-term administration of psychotropic drugs]M Bourin, J Bradwejn
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|November 21, 2001
Cholecystokinin and panic disorder: past and future clinical research strategiesJ Bradwejn, D Koszycki
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Clinical Neuropharmacology|January 1, 1992
CCK agonists and antagonists in clinical studies of panic and anxietyJ Bradwejn
Psychiatric Journal of the University of Ottawa : Revue De Psychiatrie De L'Universite D'Ottawa|June 1, 1989
Depression: a review of acute pharmacological treatmentJ Bradwejn
Journal of Psychiatry & Neuroscience : JPN|July 1, 1993
Neurobiological investigations into the role of cholecystokinin in panic disorderJ Bradwejn
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 1, 1993
Benzodiazepines for the treatment of panic disorder and generalized anxiety disorder: clinical issues and future directionsJ Bradwejn
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1991
Comparison of the panicogenic effect of cholecystokinin 30-33 and carbon dioxide in panic disorderJ Bradwejn, D Koszycki
Archives of General Psychiatry|January 1, 1995
Relationship of panic disorder to posttraumatic stress disorderG Safadi, J Bradwejn
Annals of the New York Academy of Sciences|March 23, 1994
The cholecystokinin hypothesis of anxiety and panic disorderJ Bradwejn, D Koszycki
The American Journal of Psychiatry|March 1, 1982
Reversible and irreversible tardive dyskinesia: a case reportG Chouinard, J Bradwejn
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|May 1, 1991
[Clinical and neurobiological aspects of long-term administration of psychotropic drugs]M Bourin, J Bradwejn
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|November 21, 2001
Cholecystokinin and panic disorder: past and future clinical research strategiesJ Bradwejn, D Koszycki
Pageof 10